The results announced today from the fifth cohort of the RESOLVE trial, for treatment of EoE, are derived from 12, 4 mg injections of EP-104GI (total dose of 48 mg) administered to the lower ...

During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed quality of life and the future with CAR ...

Sanofi said that Sarclisa, its treatment for plasma cell cancer, was recommended for EU approval by the European Medicines Agency. The agency's Committee for Medicinal Products for Human Use ...

An update from the PURPOSE 2 trial focused on adherence and pharmacokinetics data for lenacapavir, used to prevent HIV.

It's good news for aurora chasers as peak auroral activity occurs a few years after solar maximum, according to Brekke. This ...

As a beauty journalist, I can offer recommendations for the best mascaras without skipping a beat. Struggling with melasma? I ...

In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for patients with hereditary angioedema.

It all started with a Big Bang – and now scientists are on a quest to unravel the mystery behind the birth of the universe.

A new BLA for datopotamab deruxtecan aims for FDA accelerated approval to treat EGFR-mutated NSCLC based on data from ...

Hello, and welcome to Acumen Pharmaceuticals Q3 2024 conference call and webcast. At this time, all participants are in a listen-only mode. As of the speaker's presentation, there will be a ...

Q2 2025 Earnings Call Transcript November 13, 2024 Operator: Good day, and welcome to the Aethlon Medical Fiscal Second ...

YTN News FM Wise Radio Life] □ Broadcast Date: November 15, 2024 (Fri)□ Host: Announcer Lee Hyun-woong□ Castor: Shin Sang-yeop, Senior ...